7 security-"https:"-"https:"-"https:"-"https:" uni jobs at Center for Biologics Evaluation and Research (CBER)

FDA Research Opportunity - Detection of Emerging Pathogens that Threaten Blood Safety

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 7 days ago

-emerging transfusion-transmissible viruses (specifically hepatitis viruses) that threaten the safety of blood and blood-derived products. The project aims to advance in vitro models of infection and in vivo

FDA Non-clinical Identification and Mitigation of Safety Risks During the Development and Licensure of Protein-therapeutics

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 15 days ago

to understand the safety consequences of immune responses to neo-epitopes generated due to off-target gene editing. The following articles from our laboratory provide examples of research performed in our group

FDA Computational and Experimental Assessment of Engineered Biotherapeutics: Safety and Regulatory Considerations of Synonymous Gene Recoding

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 8 days ago

Biol, 169718 (2026). https://doi.org:10.1016/j.jmb.2026.169718 Katneni, U.K., Liss, A., Holcomb, D., Katagiri, N., Hunt, R.C., Bar, H., Ismail, A., Komar, A.A. and Kimchi-Sarfaty, C.: Splicing

FDA Research Opportunity - Immune Responses to Influenza Vaccines

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 7 days ago

. The appointment will include training on mode of action and safety of novel adjuvants used to enhance immune responses to multiple vaccines using human derived cells and organoids such as monocytes/macrophages

FDA Focus Towards More Efficient Factor VIII Drug Products to Improve the Treatment of Hemophilia A

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 5 days ago

to enhance the safety and efficacy of drug products that treat blood coagulation disorders. The selected participant will study mechanisms of plasma clearance of blood coagulation factor VIII (FVIII

FDA Evaluation of Platelets: Antimicrobial Treatments and Evaluation of the Treated Products for Functions

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 8 days ago

the following hands-on research activities: Screening of novel antimicrobial methods and reagents as treatments useful for human blood safety from microbes Evaluation of the effect of the treatments

FDA Research Opportunity in Developing Methods for Efficient Gene Editing in Hematopoietic Stem Cells (HSCs)

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 8 days ago

. Acquire skills in evaluating gene editing efficiency and safety in hematopoietic stem cells. Mentor: The mentor for this opportunity is Pankaj Kumar Mandal (pankaj.mandal@fda.hhs.gov ). If you have